Alpheus Medical
alpheusmedical.com
Actively hiring
Health Care
Oncology Therapeutics
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$107.8M
8 rounds on record
Latest round
$52M
Series B · May 2025 · 16 mo ago
Team
51-200
employees, estimated range
Backers
1
OrbiMed
The money's age
Due for its next round
16 months since the last round · not hiring
Momentum
0/100
no fresh signals
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series B | May 2025 | $52M | — | YahooFinance |
| Venture round | May 2025 | $34.5M | — | SEC Form D |
| Venture round | Oct 2022 | $14M | — | SEC Form D |
| Venture round | Dec 2020 | $6M | — | SEC Form D |
| Debt Financing | Oct 2019 | $519k | — | SEC Form D |
| Venture round | Apr 2018 | $1.3M | — | SEC Form D |
| Debt Financing | Jan 2018 | $150k | — | SEC Form D |
| Debt Financing | May 2017 | $225k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Alpheus Medical, Inc. | sec |
Founders and leadersfrom filings, registers and the company's site
Vijay AgarwalExecutive Officer, DirectorSEC Form D
Terrance KurtenbachExecutive OfficerSEC Form D
Imran EbaExecutive OfficerSEC Form D
Jeremy LingExecutive OfficerSEC Form D
Steve WeinerExecutive OfficerSEC Form D
Patrick GoraExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
OrbiMed Similar startupsby what they do, their industry and backers
Innovating life-changing medicines for cancer patients. At Kumquat, we're on a mission to transform cancer treatment by delivering durable…
TwoStep Therapeutics. Developing tumor-targeted therapies with broad applicability across solid tumors.
Targeting the Tumor Ecosystem to address cancer drug resistance and improve patients’ lives.
Third Arc Bio is advancing antibody technology by unlocking the powerful biology of immune synapses to address solid tumors and autoimmune…
Biossil is an AI native biopharma company based in Toronto. It is advancing late-stage programs in life-threatening indications with urgent…
At ITM, precision drives everything - from isotope manufacturing to cancer treatment—improving outcomes and delivering what patients and…
People
Vijay Agarwal
Executive Officer, Director
Terrance Kurtenbach
Executive Officer
Imran Eba
Executive Officer
Jeremy Ling
Executive Officer
Steve Weiner
Executive Officer
Patrick Gora
Executive Officer
William Davis
Executive Officer
Peter Thompson
Director
Klaus Veitinger
Director
Aaron Sandoski
Director
Conrad Wang
Director
Juan-Pablo Mas
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Chanhassen
United States
HQ
Corporate
50-200 est. staff
1266 Park Road, Chanhassen, MN 55317
Financials
Total raised
$108.7M
Latest round
Series B
Funding rounds
8
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Series B | 2025 | $52M | Details |
| Venture - Series Unknown | 2025 | $34.5M | Details |
| Venture - Series Unknown | 2022 | $14M | Details |
| Venture - Series Unknown | 2020 | $6M | Details |
| Debt Financing | 2019 | $519k | Details |
| Venture - Series Unknown | 2018 | $1.3M | Details |
| Debt Financing | 2018 | $150k | Details |
| Debt Financing | 2017 | $225k | Details |